arBtrage CAPITALIZING MARKETS checking… Sign in

AbCellera Biologics Inc.

ABCL Health Care Biotechnology: Pharmaceutical Preparations
$5.62
▼ -11.8% Today
as of Jun 7, 07:07 ET
Last 30 days +35.10% Apr 28 → Jun 05
$3.61 $4.37 $5.14 $5.91 $6.67 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$6.20
High
$6.33
Low
$5.50
Volume
$9M
Avg Vol
$6M
Mkt Cap
$1.7B
P/E (TTM)
Beta
52w High
$6.79
52w Low
$2.33
Div Yield
Shares Out
$304M

Overview

52-week range
$2.33
$6.79
74% of range
Avg surprise (last 2)
+24.1%
Avg reaction (last 2)
+0.1%
50% positive
Latest IV / EM
132%
EM ±18.2% · $6 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.22$-0.19$-0.16$-0.13$-0.10 Actual $-0.11Actual $-0.10Actual $-0.14Actual $-0.13Actual $-0.17Actual $-0.15Est $-0.17Actual $-0.12Actual $-0.19Actual $-0.14Est $-0.22 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-57M$-38M$-20M$-826,100$18M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Mon May 11, 2026Mar/2026 $-0.14 $-0.22 +36.4% +6.7% +0.2% earnings
Tue Sep 30, 2025Sep 2025 $-0.19 financials
Mon Jun 30, 2025Jun 2025 $-0.12 financials
Thu May 8, 2025Mar/2025 $-0.15 $-0.17 +11.8% 0.0% earnings
Mon Sep 30, 2024Sep 2024 $-0.17 financials
Sun Jun 30, 2024Jun 2024 $-0.13 financials
Sun Mar 31, 2024Mar 2024 $-0.14 financials
Sat Sep 30, 2023Sep 2023 $-0.10 financials
Fri Jun 30, 2023Jun 2023 $-0.11 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$8M$9M$17M$4M$7M$7M
Cost of revenue
Gross profit
Operating income$-58M$-76M$-50M$-63M$-94M$-93M
Net income$-43M$-57M$-35M$-46M$-51M$-37M
EPS (diluted)$-0.14$-0.19$-0.12$-0.15$-0.17$-0.13

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$77M$129M$83M$92M$159M$156M$127M$148M
Inventory$8M$6M
Total current assets$665M$728M$695M$742M$765M$751M$743M$772M
Total assets$1.31B$1.36B$1.36B$1.40B$1.34B$1.36B$1.39B$1.41B
Long-term debt
Total liabilities$369M$390M$392M$395M$321M$304M$315M$302M
Total equity$938M$967M$964M$1.01B$1.02B$1.06B$1.08B$1.11B

Implied volatility — last 90 days

126%129%131%134%136% Jun 07 — IV 132% · EM ±18.2%

Sector peers